Advertisement
Advertisement

PMCB

PMCB logo

PharmaCyte Biotech, Inc. Common Stock

0.68
USD
Sponsored
+0.03
+4.27%
Apr 13, 15:49 UTC -4
Open

PharmaCyte Biotech, Inc. Common Stock Profile

About

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.

Info & Links

CEO

Joshua N. Silverman

Headquarters

3960 HOWARD HUGHES PARKWAY, SUITE 500
LAS VEGAS, NV 89169, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.PharmaCyte.com

Auditor

Marcum LLP

Share holders

1,400

Employees

2

PharmaCyte Biotech, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

7.31M

Enterprise Value

-8.10M

Enterprise Value/EBITDA(ttm)

1.91

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.19

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

2.13%

Return on Invested Capital(ttm)

-15.64%

Return on Assets(ttm)

1.69%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-4.23M

Net Income Available to Common(ttm)

-11.04M

Diluted EPS(ttm)

-1.12

Share Statistics

Beta (5Y Monthly)

0.41

52-Week Change

-44.63%

S&P 500 52-Week Change

26.98%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

10.13M

Dividend Yield

0.00%

Float4

9.56M

% Held by Insiders

10.98%

% Held by Institutions

34.24%

Balance Sheet

Total Cash(mrq)

15.61M

Total Cash Per Share(mrq)

1.54

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

12.33%

Quick Ratio(mrq)

12.33%

Book Value Per Share(mrq)

3.55

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.41

Free Cash Flow(ytd)

-3.76M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement